ATEC(Alphatec Holdings, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。
| 科目 | FY 截至 2021-12-31 | FY 截至 2022-12-31 | FY 截至 2023-12-31 | FY 截至 2024-12-31 | FY 截至 2025-12-31 |
|---|---|---|---|---|---|
| 营业收入 | $243.21M | $350.87M | $482.26M | $611.56M | $764.15M |
| 毛利润 | $157.76M | $233.06M | $310.20M | $424.26M | $531.89M |
| 营业利润 | −$128.06M | −$146.97M | −$173.40M | −$136.17M | −$82.13M |
| 净利润 | −$143.03M | −$151.29M | −$186.64M | −$162.12M | −$143.36M |
| 经营现金流 | −$73.32M | −$75.13M | −$78.48M | −$44.65M | $45.23M |
| 自由现金流 | −$141.86M | −$124.59M | −$158.99M | −$127.87M | $2.78M |
| 摊薄每股收益 | $-1.49 | $-1.46 | $-1.54 | $-1.13 | $-0.96 |